FIBROLAMELLAR HEPATOCELLULAR CARCINOMA

Course overview

FIBROLAMELLAR HEPATOCELLULAR CARCINOMA (FL-HCC) IS A RARE CANCER OF THE LIVER AND IT DISPLAYS FEATURES THAT MAKE IT VERY DIFFERENT IN ITS BEHAVIOR AND CLINICAL FINDINGS FROM CONVENTIONAL HEPATOCELLULAR CARCINOMA (HCC)[1]. FL-HCC ACCOUNTS FOR LESS THAN 1% OF ALL PRIMARY HEPATIC MALIGNANCIES. UNLIKE CONVENTIONAL HCC, FL-HCC IS MORE COMMON IN A YOUNGER PATIENT POPULATION AND HAS A SIGNIFICANTLY LOWER INCIDENCE. THIS ACTIVITY DESCRIBES THE EVALUATION AND TREATMENT OF FL-HCC AND HIGHLIGHTS THE ROLE OF AN INTERPROFESSIONAL TEAM IN EVALUATING AND TREATING PATIENTS WITH THIS MALIGNANCY.